Skip to main content

2 results

Anti-TNF therapy could lower colorectal cancer risk for IBD patients

July 27, 2021

Maddie Bender

Receiving a colorectal cancer diagnosis on top of one for IBD may be the last thing a patient wants to hear. A patient’s risk of developing colorectal cancer depends on certain factors, including if they have ulcerative colitis or Crohn’s disease affecting the colon, they have had IBD f...

Read more...

Specific type of gut bacteria can enable development and dissemination of colorectal cancer

March 29, 2018

Scientists from Dana-Farber Cancer Institute at Harvard Medical School recently reported that a specific type of bacteria that reside in the gut can enable development and dissemination of colorectal cancer.  This type of bacteria, Fusobacterium, was previously shown to be associated w...

Read more...
Sections
Clinical Trials Community (1) Mission (1)
Topics
(X) Colorectal cancer (2)

Browser not supported

Your Internet Explorer is outdated. For optimal security settings and a better experience on our site, try switching to one of these options:

Google Chrome

Download Chrome

Firefox

Download Firefox

Safari (macOS 10.8+ only)

Download Safari